Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.

Mind Medicine (MindMed) Inc.

MindMed works to improve patient outcomes through a pipeline of novel drug candidates, focusing on the therapeutic potential of psychedelics and other compounds to address unmet needs in psychiatry, addiction, pain, and neurology.

	Aug '19	Dec '20	Dec '21	Dec '22	Dec '23
asset turnover
cash per share	0.05 -	4.51 9,448.94%	4.88 8.09%	4.61 5.56%	2.55 44.72%
company equity multiplier	1.07 -	1.07 0.17%	1.08 0.64%	1.13 4.17%	1.59 41.51%
days of inventory outstanding	-0.00 -
days of payables outstanding					477.43 -
days of sales outstanding
dividend yield
ebit per revenue
ebt per ebit	2.38 -	1.03 56.89%	0.98 4.87%	0.86 12.40%	1.02 19.11%
effective tax rate	0.00 -	-0.00 146,216.90%	0.01 354.18%	0.17 1,266.75%
enterprise value multiple	-0.54 -	-22.16 3,997.68%	-4.62 79.15%	1.00 121.59%	-0.64 163.82%
fixed asset turnover
free cash flow per share	-1.37 -	-1.33 3.28%	-1.67 25.89%	-1.62 2.92%	-1.64 1.16%
gross profit margin
interest coverage		-201.40 -	-268.42 33.28%	-44.37 83.47%
inventory turnover	-792.97K -
long term debt to capitalization					0.15 -
net income per ebt	1 -	1.00 0.48%	0.99 1.70%	0.83 15.75%	1 20.18%
net profit margin
operating cash flow per share	-0.55 -	-1.33 142.38%	-1.67 25.89%	-1.62 2.92%	-1.64 1.16%
operating profit margin
payables turnover					0.76 -
pretax profit margin
price fair value	0.10 -	10.70 10,854.99%	3.74 65.09%	0.45 87.96%	1.83 307.77%
receivables turnover
return on assets	-0.38 -	-0.42 10.11%	-0.57 35.61%	-0.28 50.99%	-0.77 176.49%
return on capital employed	-0.17 -	-0.42 146.03%	-0.63 49.13%	-0.44 30.49%	-1.02 133.21%
return on equity	-0.41 -	-0.45 10.29%	-0.61 36.48%	-0.31 48.95%	-1.23 291.25%
total debt to capitalization				0.00 -	0.15 32,014.17%

CO:MINDMED

MindMed

Last Close

7.09

22/11 21:00

Market Cap

500.56M

Beta: -

Volume Today

1.02M

Avg: -

Preview